Considering screening for hereditary cancer syndromes at the time of obstetrical prenatal carrier screening

Affiliations

• ¹ Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Weill Cornell Medicine, New York, New York, USA.
• ² Genetics and Personalized Cancer Prevention Program, Weill Cornell Medicine, New York, New York, USA.
• ³ Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai Hospital, New York, New York, USA.
• ⁴ The Blavatnik Family Women's Health Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
• ⁵ Department of Medicine and Program in Mendelian Genetics, Weill Cornell Medicine, New York, New York, USA.
• ⁶ Department of Pediatrics, Division of Medical Genetics, Weill Cornell Medicine, New York, New York, USA.
• ⁷ Department of Obstetrics and Gynecology and Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York, New York, USA.
• ⁸ Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medical Center, New York, New York, USA.
• ⁹ Division of Gastroenterology, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
• ¹⁰ Division of Epidemiology, Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA.
• ¹¹ Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, Massachusetts, USA.